Clinical trial · Interventional
Ultrasound-guided Greater Occipital Nerve Block in Children Undergoing Posterior Fossa Craniotomy
Ultrasound-guided Greater Occipital Nerve Block in Children Undergoing Posterior Fossa Craniotomy: Randomized, Controlled Study
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Surgery within the posterior fossa is associated with the highest incidence and greatest severity of acute postoperative pain that may persist beyond the immediate postoperative period. The utilization of local nerve blocks of the scalp in children may provide analgesia with stable hemodynamics while reducing the need for other anesthetics such as inhaled anesthetics and opioids. This could in turn result in less side effects, higher patient and family satisfaction, and better outcomes. The use of ultrasound-guided greater occipital nerve block (GONB) for perioperative pain management of posterior fossa surgery in pediatrics is not previously reported.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Posterior Fossa Tumor | Posterior Fossa Neoplasm | ALIAS | 0.90 |
Interventions
Interventions (2)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| control group C | Drug | — | UNRESOLVED |
| ultrasound guided Greater occipital nerve block | Drug | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- EXPERIMENTAL
- label
- Greater occipital nerve block group (group GONB)
- description
- Patient in this group will receive 2 ml of bupivacaine 0.5% (up to a maximum of 2 mg/kg) subcutaneous under ultrasound guidance in the greater occipital nerve region bilaterally.
- interventionNames
- Drug: ultrasound guided Greater occipital nerve block
- type
- PLACEBO_COMPARATOR
- label
- Control group (group C):
- description
- Patient in this group will receive the intraoperative standard of care(intraoperative intravenous fentanyl and paracetamol)
- interventionNames
- Drug: control group C
Primary outcomes (1)
- measure
- Objective Pain Scale (OPS) at 12 hours postoperative.
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 2 Years
- Maximum age
- 10 Years
Show eligibility criteria text
Inclusion Criteria: * ASA physical status I or II, * Glasgow Coma Scale (GCS) 15, * children scheduled for craniotomy for posterior fossa tumors Exclusion Criteria: * Refusal of patients guardians * Patients with suspected or proved allergic to local anesthetics * Emergency surgery, * Children with GCS \< 15 * Craniotomy incision beyond the coverage of the block will be excluded from the study.
References
Publications (0)
Data not yet available